COMPASS FINANCIAL MANAGEMENT LLC’s Pfizer PFE Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$578K	Buy	+23,884	New	+$625K	0.07%	253

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's PFE Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Pfizer (PFE) in Q2 2026: 23,884 shares worth $578K. The stake represents 0.07% of the portfolio and ranks #253 among its holdings.

2,246 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

COMPASS FINANCIAL MANAGEMENT LLC held 23,884 shares of Pfizer worth $578K as of Q2 2026.
Pfizer was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
Pfizer made up 0.07% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #253 holding.
2,246 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.